Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
90,318,827
-
Total 13F shares
-
100,531,669
-
Share change
-
+2,497,301
-
Total reported value
-
$1,487,837,300
-
Put/Call ratio
-
23%
-
Price per share
-
$14.80
-
Number of holders
-
208
-
Value change
-
+$12,972,113
-
Number of buys
-
115
-
Number of sells
-
114
Institutional Holders of Travere Therapeutics, Inc. - COMMON STOCK (TVTX) as of Q2 2025
As of 30 Jun 2025,
Travere Therapeutics, Inc. - COMMON STOCK (TVTX) was held by
208 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
100,531,669 shares.
The largest 10 holders included
JANUS HENDERSON GROUP PLC, ARMISTICE CAPITAL, LLC, BlackRock, Inc., VANGUARD GROUP INC, MACQUARIE GROUP LTD, STATE STREET CORP, ADAGE CAPITAL PARTNERS GP, L.L.C., RENAISSANCE TECHNOLOGIES LLC, EMERALD ADVISERS, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
208
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.